| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10869845 | OPERAND PHARMS | Ephedrine compositions and methods |
Jan, 2040
(15 years from now) | |
Ephedrine Sulfate is owned by Operand Pharms.
Ephedrine Sulfate contains Ephedrine Sulfate.
Ephedrine Sulfate has a total of 1 drug patent out of which 0 drug patents have expired.
Ephedrine Sulfate was authorised for market use on 22 April, 2022.
Ephedrine Sulfate is available in solution;intravenous dosage forms.
The generics of Ephedrine Sulfate are possible to be released after 22 January, 2040.
Drugs and Companies using EPHEDRINE SULFATE ingredient
Market Authorisation Date: 22 April, 2022
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
How can I launch a generic of EPHEDRINE SULFATE before it's drug patent expiration?
More Information on Dosage
EPHEDRINE SULFATE family patents
